VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 1, 2026
Stock Comparison
Hilton Worldwide Holdings Inc. vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Hilton Worldwide Holdings Inc.
HLT · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Hilton Worldwide Holdings Inc.'s moat claims, evidence, and risks.
View HLT analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 72 / 100 for Hilton Worldwide Holdings Inc.).
- Segment focus: Hilton Worldwide Holdings Inc. has 2 segments (72.7% in Management and Franchise); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Hilton Worldwide Holdings Inc. has 5 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Hilton Worldwide Holdings Inc.
Management and Franchise
Hotel management, franchising and brand licensing
Global
Third-party hotel owners / franchisees and strategic partners
Franchisor / manager / IP licensor
72.7%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Hilton Worldwide Holdings Inc. strengths
Novo Nordisk A/S strengths
Segment mix
Hilton Worldwide Holdings Inc. segments
Full profile >Management and Franchise
Oligopoly
Ownership
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.